Company / R&D per Share
STANDARD BIOTOOLS INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.07
FY2025
5-year range
$0.07 / $0.49
FY2021-FY2025
Trend
-85.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 3 consecutive years, from $0.49 in FY2022 to $0.07 in FY2025.
Based on SEC 10-K filings.
0.07 in FY2025 with a 5-year CAGR of -30.7%.
Declined from $0.47 to $0.07 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -48.2%
- 5-Year CAGR
- -30.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- STANDARD BIOTOOLS INC.'s r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 85.2% year-over-year.
- Peak r&d per share was recorded in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -85.2% |
| FY2024 | $0.47 | -0.9% |
| FY2023 | $0.47 | -4.7% |
| FY2022 | $0.49 | +16.2% |
| FY2021 | $0.42 | -1.1% |
| FY2020 | $0.43 | -31.3% |
| FY2019 | $0.62 | -36.9% |
| FY2018 | $0.99 | -26.3% |
| FY2017 | $1.34 | -10.7% |
| FY2016 | $1.51 | +113.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026